MUC1 as a target for CAR‐T therapy in head and neck squamous cell carinoma

The modification of chimeric antigen receptor (CAR) endowing T cells with tumor‐specific cytotoxicity induces antitumor immunity. However, the structural characteristics of solid tumors, the loss of specific antigens, and the strong immunosuppressive environment are challenges to treat solid tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Zi, Zhang, Kai, Lam, Alfred King‐Yin, Huang, Junwen, Qiu, Feng, Qiao, Bin, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970025/
https://www.ncbi.nlm.nih.gov/pubmed/31800160
http://dx.doi.org/10.1002/cam4.2733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970025/
https://www.ncbi.nlm.nih.gov/pubmed/31800160
http://dx.doi.org/10.1002/cam4.2733

Ejemplares similares